Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Treatment of acute myeloblastic leukemia
B. D. Clarkson
, M. D. Dowling
, T. S. Gee
, J. H. Burchenal
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of acute myeloblastic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Remission
100%
Acute Myeloblastic Leukemia
100%
6-thioguanine (6-TG)
42%
Previously Untreated Patients
28%
Multiple Drugs
14%
Chemotherapy
14%
Response Rate
14%
Remission Induction
14%
Duration of Response
14%
Previously Treated Patients
14%
Adequate Therapy
14%
Complex Sequences
14%
Repeated Courses
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Cytarabine
100%
Tioguanine
100%
Intravenous Drug Administration
33%
Chemotherapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Acute Myeloid Leukemia
100%
Cytarabine
37%
Tioguanine
37%
Chemotherapy Regimens
12%